Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF) Sees Significant Drop in Short Interest

Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF) was the recipient of a large decline in short interest in the month of August. As of August 31st, there was short interest totalling 1,100 shares, a decline of 54.2% from the August 15th total of 2,400 shares. Based on an average daily trading volume, of 1,500 shares, the short-interest ratio is presently 0.7 days.

Separately, Zacks Investment Research downgraded Ortho Regenerative Technologies from a “buy” rating to a “hold” rating in a report on Friday, August 27th.

OTCMKTS:ORTIF remained flat at $$0.38 on Friday. Ortho Regenerative Technologies has a 1 year low of $0.00 and a 1 year high of $0.81. The firm has a fifty day moving average price of $0.33 and a two-hundred day moving average price of $0.38.

Ortho Regenerative Technologies (OTCMKTS:ORTIF) last released its earnings results on Tuesday, June 29th. The company reported ($0.03) earnings per share for the quarter. As a group, research analysts expect that Ortho Regenerative Technologies will post -0.11 EPS for the current year.

About Ortho Regenerative Technologies

Ortho Regenerative Technologies, Inc is a clinical stage orthobiologics company, which engages in the development of novel therapeutic soft tissue repair technologies for sports medicine surgeries. Its product pipeline include Rotator Cuff Repair, Meniscal Repair, and R&D Portfolio. The company was founded on February 5, 2015 and is headquartered in Kirkland, Canada.

Featured Article: What is an economic bubble?

Receive News & Ratings for Ortho Regenerative Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ortho Regenerative Technologies and related companies with MarketBeat.com's FREE daily email newsletter.